MCF Advisors’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-42,854
| Closed | -$411K | – | 1037 |
|
|
2024
Q4 | $411K | Sell |
42,854
-204,170
| -83% | -$1.96M | 0.03% | 159 |
|
|
2024
Q3 | $706K | Hold |
247,024
| – | – | 0.05% | 112 |
|
|
2024
Q2 | $721K | Hold |
247,024
| – | – | 0.05% | 108 |
|
|
2024
Q1 | $788K | Hold |
247,024
| – | – | 0.06% | 102 |
|
|
2023
Q4 | $830K | Buy |
247,024
+204,170
| +476% | +$686K | 0.07% | 96 |
|
|
2023
Q3 | $102K | Hold |
42,854
| – | – | 0.01% | 285 |
|
|
2023
Q2 | $75.4K | Hold |
42,854
| – | – | 0.01% | 316 |
|
|
2023
Q1 | $132K | Hold |
42,854
| – | – | 0.01% | 246 |
|
|
2022
Q4 | $227K | Sell |
42,854
-9,000
| -17% | -$47.7K | 0.02% | 198 |
|
|
2022
Q3 | $183K | Sell |
51,854
-7,805
| -13% | -$27.5K | 0.02% | 206 |
|
|
2022
Q2 | $154K | Buy |
59,659
+2,190
| +4% | +$5.65K | 0.02% | 207 |
|
|
2022
Q1 | $257K | Buy |
+57,469
| New | +$257K | 0.02% | 166 |
|
|
2021
Q4 | – | Sell |
-66,185
| Closed | -$482K | – | 724 |
|
|
2021
Q3 | $482K | Buy |
66,185
+29,431
| +80% | +$214K | 0.05% | 104 |
|
|
2021
Q2 | $368K | Hold |
36,754
| – | – | 0.04% | 119 |
|
|
2021
Q1 | $351K | Buy |
+36,754
| New | +$351K | 0.04% | 116 |
|
|
2020
Q4 | – | Sell |
-45,833
| Closed | -$407K | – | 490 |
|
|
2020
Q3 | $407K | Buy |
+45,833
| New | +$407K | 0.05% | 85 |
|